OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms
Lei Xiao, Xin Nie, Yanyan Cheng, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 35, Iss. 6, pp. 1253-1267
Closed Access | Times Cited: 11
Lei Xiao, Xin Nie, Yanyan Cheng, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 35, Iss. 6, pp. 1253-1267
Closed Access | Times Cited: 11
Showing 11 citing articles:
Diabetes Mellitus and Heart Failure
Filippos Triposkiadis, Αndrew Xanthopoulos, Αlexandra Bargiota, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3682-3682
Open Access | Times Cited: 46
Filippos Triposkiadis, Αndrew Xanthopoulos, Αlexandra Bargiota, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3682-3682
Open Access | Times Cited: 46
SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials
Guijun He, Guosu Yang, Xiaoyu Huang, et al.
Heart & Lung (2023) Vol. 59, pp. 109-116
Open Access | Times Cited: 19
Guijun He, Guosu Yang, Xiaoyu Huang, et al.
Heart & Lung (2023) Vol. 59, pp. 109-116
Open Access | Times Cited: 19
GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
Georgios S. Papaetis
Archives of Medical Science - Atherosclerotic Diseases (2023) Vol. 8, Iss. 1, pp. 19-34
Open Access | Times Cited: 18
Georgios S. Papaetis
Archives of Medical Science - Atherosclerotic Diseases (2023) Vol. 8, Iss. 1, pp. 19-34
Open Access | Times Cited: 18
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
Georgios S. Papaetis, Michalis Picolos, Anastasia Sacharidou
Archives of Medical Science - Atherosclerotic Diseases (2025) Vol. 10, Iss. 1, pp. 1-15
Open Access
Antidiabetic Advancements In Silico: Pioneering Novel Heterocyclic Derivatives through Computational Design
Anuradha Mehra, Aryan Mehra
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 2
Anuradha Mehra, Aryan Mehra
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 2
AMPK-mediated autophagy is involved in the protective effect of canagliflozin in the vitamin D3 plus nicotine calcification model in rats
Wafaa A. Hewedy, Shaymaa A. Abdulmalek, Doaa A. Ghareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 2, pp. 873-888
Open Access | Times Cited: 5
Wafaa A. Hewedy, Shaymaa A. Abdulmalek, Doaa A. Ghareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 2, pp. 873-888
Open Access | Times Cited: 5
Autosis: a new form of cell death in myocardial ischemia–reperfusion injury
Xiaoting Yang, Hui Wu, Gang Zhou, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Xiaoting Yang, Hui Wu, Gang Zhou, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Antihypertensive Effects of SGLT-2 Inhibitors and Progress in Research
小寒 夏
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3028-3036
Closed Access
小寒 夏
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3028-3036
Closed Access
The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
Joaquim Barreto, Alessandra M. Campos‐Staffico, Wilson Nadruz, et al.
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 1
Joaquim Barreto, Alessandra M. Campos‐Staffico, Wilson Nadruz, et al.
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 1
Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes
Angeliki Bourazana, Grigorios Giamouzis, John Skoularigis, et al.
World Journal of Cardiology (2022) Vol. 14, Iss. 4, pp. 266-270
Open Access | Times Cited: 1
Angeliki Bourazana, Grigorios Giamouzis, John Skoularigis, et al.
World Journal of Cardiology (2022) Vol. 14, Iss. 4, pp. 266-270
Open Access | Times Cited: 1
Insilico designing of novel imidazothiadiazole derivatives as SGLT2 inhibitors in emerging potential for Antidiabetic Therapeutics
Anuradha Mehra
Research Square (Research Square) (2023)
Open Access
Anuradha Mehra
Research Square (Research Square) (2023)
Open Access
